Luye Pharma Group Ltd.

SEHK:2186 주식 보고서

시가총액: HK$9.9b

Luye Pharma Group 대차 대조표 상태

재무 상태 기준 확인 4/6

Luye Pharma Group 의 총 주주 지분은 CN¥14.1B 이고 총 부채는 CN¥9.4B, 이는 부채 대 자기자본 비율을 66.6% 로 가져옵니다. 총자산과 총부채는 각각 CN¥27.2B 및 CN¥13.1B 입니다. Luye Pharma Group 의 EBIT는 CN¥1.3B 이며 이자보상배율은 2.9 입니다. CN¥6.5B 의 현금 및 단기 투자금을 보유하고 있습니다.

주요 정보

66.6%

부채 비율

CN¥9.39b

부채

이자 보상 비율2.9x
현금CN¥6.48b
주식CN¥14.08b
총 부채CN¥13.11b
총 자산CN¥27.20b

최근 재무 상태 업데이트

Recent updates

Unpleasant Surprises Could Be In Store For Luye Pharma Group Ltd.'s (HKG:2186) Shares

Sep 25
Unpleasant Surprises Could Be In Store For Luye Pharma Group Ltd.'s (HKG:2186) Shares

Does Luye Pharma Group (HKG:2186) Have A Healthy Balance Sheet?

Aug 29
Does Luye Pharma Group (HKG:2186) Have A Healthy Balance Sheet?

Luye Pharma Group Ltd.'s (HKG:2186) Earnings Haven't Escaped The Attention Of Investors

Jun 19
Luye Pharma Group Ltd.'s (HKG:2186) Earnings Haven't Escaped The Attention Of Investors

We Discuss Why Luye Pharma Group Ltd.'s (HKG:2186) CEO Compensation May Be Closely Reviewed

May 21
We Discuss Why Luye Pharma Group Ltd.'s (HKG:2186) CEO Compensation May Be Closely Reviewed

Here's Why Luye Pharma Group (HKG:2186) Has A Meaningful Debt Burden

Apr 26
Here's Why Luye Pharma Group (HKG:2186) Has A Meaningful Debt Burden

Is Luye Pharma Group Ltd. (HKG:2186) Trading At A 27% Discount?

Feb 29
Is Luye Pharma Group Ltd. (HKG:2186) Trading At A 27% Discount?

Some Confidence Is Lacking In Luye Pharma Group Ltd.'s (HKG:2186) P/S

Jan 09
Some Confidence Is Lacking In Luye Pharma Group Ltd.'s (HKG:2186) P/S

Luye Pharma Group (HKG:2186) Takes On Some Risk With Its Use Of Debt

Dec 19
Luye Pharma Group (HKG:2186) Takes On Some Risk With Its Use Of Debt

A Look At The Fair Value Of Luye Pharma Group Ltd. (HKG:2186)

Nov 24
A Look At The Fair Value Of Luye Pharma Group Ltd. (HKG:2186)

Is Luye Pharma Group (HKG:2186) A Risky Investment?

Sep 12
Is Luye Pharma Group (HKG:2186) A Risky Investment?

Luye Pharma Group Ltd.'s (HKG:2186) Intrinsic Value Is Potentially 20% Below Its Share Price

Aug 17
Luye Pharma Group Ltd.'s (HKG:2186) Intrinsic Value Is Potentially 20% Below Its Share Price

Is Luye Pharma Group (HKG:2186) Using Too Much Debt?

May 10
Is Luye Pharma Group (HKG:2186) Using Too Much Debt?

We Think Luye Pharma Group (HKG:2186) Is Taking Some Risk With Its Debt

Sep 20
We Think Luye Pharma Group (HKG:2186) Is Taking Some Risk With Its Debt

Time To Worry? Analysts Just Downgraded Their Luye Pharma Group Ltd. (HKG:2186) Outlook

Apr 06
Time To Worry? Analysts Just Downgraded Their Luye Pharma Group Ltd. (HKG:2186) Outlook

Luye Pharma Group's (HKG:2186) Shareholders Are Down 31% On Their Shares

Mar 17
Luye Pharma Group's (HKG:2186) Shareholders Are Down 31% On Their Shares

재무 상태 분석

단기부채: 2186 의 단기 자산 ( CN¥12.5B )이 단기 부채( CN¥9.8B ).

장기 부채: 2186 의 단기 자산( CN¥12.5B )이 장기 부채( CN¥3.3B ).


부채 대 자본 내역 및 분석

부채 수준: 2186 의 순부채 대 자기자본 비율( 20.6% )은 satisfactory로 간주됩니다.

부채 감소: 2186 의 부채 대 자기자본 비율은 지난 5년간 70.7% 에서 66.6% 로 감소했습니다.

부채 범위: 2186 의 부채는 영업 현금 흐름 ( 5.4% )에 의해 잘 갚지 않음입니다.

이자 보장: 2186 의 부채에 대한 이자 지급EBIT( 2.9 x 적용 범위)만큼 잘 덮이지 않음입니다.


대차 대조표


건강한 기업 발견하기